Shares of GSK rose on Thursday after the company announced it had begun shipping its seasonal flu vaccines, Fluarix and ...

The (first) flu shot is free for people who meet certain criteria, such as being 65 and over, pregnant, Aboriginal and Torres ...

Moderna MRNA announced that its seasonal influenza vaccine candidate, mRNA-1010, achieved superior relative vaccine efficacy (rVE) than an approved flu shot marketed by GSK plc GSK in a phase III ...

The poster has two rough holes in the middle where it was tied around an upright at the Greenbelt Metro. The Greenbelt Metro Community Vaccination Center (CVC) was established and run by FEMA (Federal ...

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

Moderna, Inc. (MRNA) announced Monday positive results from a Phase 3 efficacy study evaluating the relative vaccine efficacy (rVE) against influenza illness of mRNA-1010, the Company's seasonal ...

Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product ...

A US vaccine advisory panel voted Thursday to stop recommending flu shots that contain thimerosal, a move that experts say may reduce access to vaccines without making them any safer.

A CDC panel recommended against flu vaccines with thimerosal, a preservative falsely linked to autism. Experts warn the decision may raise vaccine costs unnecessarily.

Current flu vaccines contain three different strains of influenza, which are selected by doctors who monitor what strains are circulating toward the tail end of the prior flu season.